LEFT VENTRICULAR HYPERTROPHY RISK FACTOR IN PATIENTS WITH END STAGE RENALE DISEASE TREATED WITH HAEMODIALYSIS
Journal Title: Acta Medica Balkanica - International Journal of Medical Sciences - Year 2019, Vol 4, Issue 7
Abstract
Cardiovascular diseases (CVD) are the main cause of morbidity and mortality in patients suffering from End- Stage Renal Disease (ESRD) and undergoing treatment by long-term haemodialysis. One of the complications for uremic patients during the treatment by haemodialysis (HD) is Left Ventricular Hypertrophy (LVH) which begins during the early phases of the diseases which is not related to the underlying renal disease. Involvement of CVD (acute myocardial infarction, arrhythmia, congestive cardiac failure, angina pectoris stable and unstable) lately are described as cardio-renal diseases (Goldmani et al., 2016). The cardiovascular complications may appear at any phase of ESRD regardless the Glomerular Filtration Rate (GFR). CVD are present in 75 % of the patients treated with long-term HD beginning in Phase III NKF-K/DOQI (National Kidney Foundation – Kidney/ Disease Outcomes Quality Initiative).The LVH assessment is heterogeneous, but with the standard examination assistance(echocardiography, electrocardiography, computer tomography, magnetic resonance imaging) it can be used to diagnose exactly the mentioned disease. Purpose of study: The aim of the study was to detect and verify the prevalence of left ventricular hypertrophy in patients with ESRD treated with long term hemodialysis (HD). Conclusion: The risk of left ventricular hypertrophy and cardiovascular diseases in patients with renal chronic disease and patients treated with long-term haemodialysis increases with progression of disease and decrease of GFR. LVH and CVD are independent risk factors for high mortality rates in uremic patients treated with long- term haemodialysis. Early detection and adequate treatment LVH should begin in the early phases of the diseases and should be the first step undertaken by nephrologists, with the sole purpose of their prevention.
Authors and Affiliations
Lutfi Zylbeari, Kastriot Haxhirexha, Sadi Bexheti, Veton Ademi, Zamira Bexheti
Keywords
Related Articles
- EP ID EP655564
- DOI -
- Views 212
- Downloads 0
UREMIC PLEURITIS
One complication of treatment of hemodialysis in uremic patients is also exudative pleuritis. As a consequence of the expanded use of long-term hemodialysis treatment and the extended life spans, complications of chronic...
THE ALTERATIONS OF THE ENZYMATIC ANTIOXYDANT ACTIVITY BY ADDING ALKALINE WATER ON THE WHITE LABORATORY RATS AFTER HYPERTHERMIC STRESS
Alkaline water is in the focus of scientific interest over the last decade, due to its ability to alkalize the organism as well as its antioxidant effect. Due the hyperthermia, systemic and cellular changes occurs. Addin...
VITAMIN D DEFICIENCY IN TETOVA REGION
Vitamin D is an essential nutrient needed to promote bone growth in children’s and adults. Normally vitamin D can be synthesized in the skin by exposure to sunlight, however during the winter and part of autumn is recomm...
COAL DUST IMPACT AND THE PRESENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN EXPOSED WORKERS IN KOSOVO POWER PLANT
Chronic Obstructive Pulmonary Disease (COPD) is a condition that is characterized by airflow limitation that is not fully reversible and worsens with time. Worldwide, cigarette smoking is the most commonly encountered ri...
THE VALUES OF CARDIAC TROPONIN IN ACUTE CORONARY SYNDROME
Acute Coronary Syndrome (ACS) is the factor with the highest rate of morbidity and mortality. ACS compromises Myocardial Infarction (MI), and Unstable Angina or sharp, sudden chest pain which typically appears when the p...